- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
AstraZeneca Pharma India Limited — Updates, 10-02-2026: General Updates
10-02-2026 | 10:56 am
10-02-2026 | 10:56 am
AstraZeneca India secured key drug approval to launch Durvalumab (Imfinzi) for an additional cancer indication. This expands the drug's market reach in India, potentially boosting sales.
No comments yet. Be the first to comment!